Updated: April 17, 2021 RubrYc Therapeutics announces a research collaboration and license option agreement with Zai Labs Must Read Nationalindonesianupdates.com_admin - October 31, 2026Authority suspects deliberate acts behind 1,600 hectares of IKN fires Nationalindonesianupdates.com_admin - October 31, 2026Indonesia urges strict AI risk mitigation in finance, healthcare Nationalindonesianupdates.com_admin - October 31, 2026OIKN joins tree planting to restore fire-hit forest in Nusantara RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the … Previous articleA digital transformation: Mary Kay Inc. launches immersive virtual experience platform Suite 13TMNext articleEmbassy, Malaysian police rescue abused, unpaid Indonesian maid Latest News Nationalindonesianupdates.com_admin - October 31, 2026Authority suspects deliberate acts behind 1,600 hectares of IKN firesBalikpapan, East Kalimantan (ANTARA) - The Nusantara Capital City Authority (OIKN) reported that 1,600 hectares of forest and land in... National Indonesia urges strict AI risk mitigation in finance, healthcare indonesianupdates.com_admin - October 31, 2026 National OIKN joins tree planting to restore fire-hit forest in Nusantara indonesianupdates.com_admin - October 31, 2026 National RI, Uzbekistan form committee for food security, trade indonesianupdates.com_admin - October 31, 2026 National Bali immigration deports Indian national over dual-identity passports indonesianupdates.com_admin - October 31, 2026 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the …